-->
FOX NEWS: Antibody drug cuts moderate Alzheimer’s decline, Swiss biotech cautions over results

FOX NEWS: Antibody drug cuts moderate Alzheimer’s decline, Swiss biotech cautions over results


Antibody drug cuts moderate Alzheimer’s decline, Swiss biotech cautions over results



Baca Juga

A Phase 2 trial involving an investigational monoclonal antibody drug, semorinemab, targeting the tau protein, reduced cognitive decline among adults with mild-to-moderate Alzheimer’s disease by about 44%, Swiss biotech AC Immune announced Tuesday.

via FOX NEWS https://ift.tt/3mS57V0

Related Posts

0 Response to "FOX NEWS: Antibody drug cuts moderate Alzheimer’s decline, Swiss biotech cautions over results"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel